IGS GeboJagema

IGS GeboJagema is a high-precision mould solution company that collaborates with OEMs early in the lifecycle, on the design, manufacture, validation and maintenance of moulds for products where extreme precision is vital, including asthma inhalers, insulin pens and diagnostic devices.

Headquarters
IGS GeboJagema
Esp 430
5633 AJ Eindhoven
The Netherlands

Phone / Contact

T: +31 402 647 500
E: [email protected]

Connect

IGS GeboJagema is a high-precision mould maker that designs, manufactures, validates and maintains moulds for products where extreme precision is vital, from glasses and contact lenses to asthma inhalers, insulin pens and blood diagnostic devices.

IGS GeboJagema specialises in collaborating with medical original equipment manufacturers (OEMs) early in the product lifecycle, allowing its exceptional engineering team to develop innovative moulding solutions.

The company was founded in 1945 in Tilburg, the Netherlands, as a supplier of Instruments, Tools (which in Dutch are Gereedschappen) and Stamps (Stempels in Dutch), hence the abbreviation to IGS. It is privately owned by Smile Investments (Leuven, Belgium), which acquired it in 2021 from Nordian Capital.

Articles by IGS GeboJagema

FROM VISION TO VICTORY: BUILDING A HANDS-ON ESG FRAMEWORK

Herman Rusch and Steven van Voorst discuss the steps that IGS GeboJagema has taken to provide its ESG efforts with a robust structure to build on and how doing so has made those efforts more effective and provided the company with clear, meaningful and measurable targets to work towards.

INDUSTRIALISATION

IMPLEMENTING INDUSTRY 4.0: LESSONS LEARNED OVER TWO DECADES

Herman Rusch and Rob van den Brand present four lessons for implementing Industry 4.0 technology and practices in the drug delivery industry, which IGS GeboJagema has learned during its own journey to Industry 4.0 over the past 20 years.

GREEN THINKING: HOW TO BECOME A MORE SUSTAINABLE ORGANISATION

André Jansen and Ron Cisliek describe how high-precision mould maker IGS GeboJagema is fostering a culture of “green thinking” and making sustainability a core part of its business.

INDUSTRIALISATION

STREAMLINING DRUG DELIVERY DEVICE DEVELOPMENT FOR INDUSTRIALISATION SUCCESS

Hans Arts, Jan-Willem Den Hollander and Ron Cisliek discuss the value of bringing an industrialisation partner on board early in product development and how working with a single manufacturing specialist can preserve insights and learnings throughout the product development lifecycle and deliver additional value and quality.

INDUSTRIALISATION

HIGH-PRECISION INJECTION MOULDS FOR INHALERS: CHALLENGES AND SOLUTIONS

Rob Doorakkers and Erwin van Huijksloot discuss the challenges and solutions of engineering and manufacturing high-precision injection moulds for inhalers.

SMART SOLUTIONS TO REDUCE CARBON FOOTPRINT

Rob Doorakkers and Geert van Amstel discuss why the company decided to become carbon neutral, how it is working to make injection moulding more sustainable and how the organisation is minimising its impact on the environment.

INDUSTRIALISATION

HOW MODEL BASED DEFINITION REVOLUTIONISES THE PRODUCTION OF MEDICAL DEVICES

Rob Doorakkers looks at the advantages of the IGS GeboJagema’s Model Based Definition process and its ability to improve the quality of medical device production.

Top